Cargando…
Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report
BACKGROUND: Pericarditis, along with myocarditis, is being increasingly reported after the coronavirus disease 2019 (COVID-19) vaccine, but the best treatment strategy in this specific setting is still unclear. CASE SUMMARY: We report a case of acute pericarditis after the second dose of mRNA COVID-...
Autores principales: | Perna, Francesco, Verecchia, Elena, Pinnacchio, Gaetano, Gerardino, Laura, Brucato, Antonio, Manna, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992233/ https://www.ncbi.nlm.nih.gov/pubmed/35445166 http://dx.doi.org/10.1093/ehjcr/ytac123 |
Ejemplares similares
-
Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report
por: Conte, C, et al.
Publicado: (2022) -
Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report
por: Thomson, Ross J, et al.
Publicado: (2021) -
When cardiac surgery comes to its limits: a case report of pericardial mesothelioma invading the myocardium
por: Pölzl, Leo, et al.
Publicado: (2021) -
A Focus on Relapsed Multiple Myeloma
por: Noonan, Kimberly, et al.
Publicado: (2022) -
A Focus on Special Populations in Relapsed Multiple Myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)